F2G
PrivateLast Round
Series H
Sep 12, 2024
Total Funding Raised
$103.45M
Company Overview
F2G is a biotechnology company that develops novel therapies for the treatment of life-threatening invasive fungal infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
F2G Comparables
Compare F2G with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biosergen AB | 84% | |
| Basilea Pharmaceutica | 80% | |
| Scynexis Inc | 78% | |
F2G Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series H | Sep 12, 2024 | ||||
| VC Round | Aug 4, 2022 | ||||
| Series F | Aug 12, 2020 | ||||
| VC Round | Jan 7, 2019 | ||||
| Debt | Nov 22, 2018 | ||||
VC Round | Jun 20, 2016 |
F2G Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Heartcore Capital | VC Round |
| Owl Rock Capital Group | Series H |
| AMR Action Fund | Series H |
| Brace Pharma Capital | Series H, VC Round, Series F |
| Forbion | Series H, VC Round |
| BankInvest | Series A |
| Intermediate Capital Group | Series H |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2024
$100M round led by Intermediate Capital Group and AMR Action Fund.
- Aug 4, 2022
$70M round led by Forbion and Sofinnova Partners.
F2G Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about F2G's valuation, stock price, and market status.